
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [CRSP] CRISPR Therapeutics AG
Data updated 2025-Jul-09 (Wednesday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab

Share
2025-Jul-09 Wednesday
Open | $55.90 | High | $60.13 +7.57% |
---|---|---|---|
Close | $60.08 | Low | $55.79 -0.20% |
Volume | 5.31 Million 0.73x | Volatility | 7.78% |
Change |
+$5.26
+9.60%
|
Streak | ↑ 2 days +17.37% |
20d SMA | $47.09 +27.6% | 50d SMA | $41.34 +45.3% | 100d SMA | $41.09 +46.2% | 200d SMA | $43.31 +38.7% |
RSI | 85 | MACD | 1.05 | ADX | 41.0 | Stochastic Oscillator | 93.8 92.1 |
CCI | 215.3 | ATR | 2.83 | OBV | 15 Million | Chaikin A/D | -35.1 Million |
Market Cap | 5.22 B | PEG Ratio | Trailing P/E | 124 | Forward P/E | ||
Price/Sales (ttm) | 13.9 | Price/Book (mrq) | 2.77 | EV/Revenue (ttm) | 10.2 | EV/EBITDA (ttm) | -18.6 |
% Held by Insiders | 1.42% | % Held by Institutions | 66.81% | Shares Short | 14.7 M | Shares Short (prior month) | 14.9 M |
Short Ratio | 6.82 | Short % of Outstanding | 18.34% | Short % of Float | 18.59% | Shares Short Change (mom) | -1.0% |
Revenue/Share (ttm) | $4.69 | Profit Margin (ttm) | -41.38% | Operating Margin (ttm) | 34.58% | EBITDA (ttm) | -203 M |
Diluted EPS (ttm) | $-1.94 | Current Ratio (mrq) | 17.5 | Return on Assets (ttm) | -6.22% | Return on Equity (ttm) | -8.17% |
Qtr Earnings Growth (yoy) | Qtr Revenue Growth (yoy) | Operating Cash Flow (ttm) | -260 M | Free Cash Flow (ttm) | -239 M | ||
Choose view type
Monthly Performance for CRISPR Therapeutics AG. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for CRISPR Therapeutics AG up to close of 2025-Jul-09 at $60.08
2-year Performance Benchmarks for CRISPR Therapeutics AG:
Related to CRISPR Therapeutics AG
Information for CRISPR Therapeutics AG
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Jul-09 on Google
SEC Reports : Quarterly reports around 2025-Jul-09 on SEC Edgar
Compare CRISPR Therapeutics AG with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes CRISPR Therapeutics AG
Industry : Biotechnology industry performance which includes CRISPR Therapeutics AG